Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Teva withdraws US filing for cancer biologic

FDA requests more data for balugrastim

Voltarra names new CEO

Richard Becker has experience at Alcon, Merck, Novartis, OSI, Bayer and BASF

- PMLiVE

Grey/Ogilvy alliance wins two GSK accounts

WPP’s GO Team to lead on two antacid brands

- PMLiVE

New medical director for Healthcare UK

Rory Shaw to lead team to spread NHS expertise worldwid

- PMLiVE

Bupa mockumentary to get people walking

Uses spoof character Chad Strider as part of global digital marketing campaign

- PMLiVE

EMA warns of excessive caution by regulators

Agency says risk aversion could deny patients new treatments

Sanofi reception

Sanofi pulls development of blood cancer drug

Fedratinib linked to brain disorder during clinical trials

- PMLiVE

Baxter licenses cancer drug from CTI in $172m deal

Pacritinib is being investigated to treat blood disorder myelofibrosis

Bayer symbol

EU approval for Bayer’s prostate cancer drug

Xofigo wins marketing authorisation from European Commission

- PMLiVE

MedImmune appoints head of research

Yong-Jun Liu to lead R&D at AstraZeneca biologics subsidiary

- PMLiVE

New shores: The shift from selling pills

The shift from just selling pills to developing value-added services has only just begun

- PMLiVE

He who dares wins

The benefits of including medical experts in your brand planning team

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links